A recent study revealed that the effector function of CD8+CD27+CXCR3−T cells is overactive in active SLE compared with healthy controls and patients in remission, and this overactivity is positively associated with clinical SLE activity (60). The gene discussed is CD8A; the disease is systemic lupus erythematosus.